1 Min Read
Feb 22 (Reuters) - Novartis Ag:
* SAYS TREATMENT WITH NOVARTIS’ ULTIBRO BREEZHALER IMPROVED CARDIAC FUNCTION IN COPD PATIENTS WITH LUNG HYPERINFLATION Further company coverage: (Reporting by John Miller)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.